AbbVie
ABBV
#27
Rank
โ‚น26.720 T
Marketcap
โ‚น15,105
Share price
0.71%
Change (1 day)
7.13%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : โ‚น11.347 Trillion

According to AbbVie's latest financial reports the company's total liabilities are โ‚น11.347 Trillion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

AbbVie - Total liabilities on balance sheet (from 2011 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚น11.306 T9.25%
2023-12-31โ‚น10.348 T2.92%
2022-12-31โ‚น10.055 T3.06%
2021-12-31โ‚น9.757 T-2.95%
2020-12-31โ‚น10.053 T44.91%
2019-12-31โ‚น6.937 T46.34%
2018-12-31โ‚น4.740 T13.03%
2017-12-31โ‚น4.194 T0.42%
2016-12-31โ‚น4.176 T27.99%
2015-12-31โ‚น3.263 T99.79%
2014-12-31โ‚น1.633 T7.01%
2013-12-31โ‚น1.526 T17.9%
2012-12-31โ‚น1.294 T222.48%
2011-12-31โ‚น401.45 B64.94%
2010-12-31โ‚น243.39 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚น10.754 T-5.23%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น6.562 T-42.17%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น5.548 T-51.10%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น7.401 T-34.78%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น3.422 T-69.84%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น975.81 B-91.40%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น5.011 T-55.84%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น5.438 T-52.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น97.20 B-99.14%๐Ÿ‡บ๐Ÿ‡ธ USA